Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Oct 3;273(3):10.1016/j.taap.2013.09.023. doi: 10.1016/j.taap.2013.09.023

Figure 1.

Figure 1

Liver injury in C56Bl/6 mice after treatment with galactosamine/endotoxin (Gal/End), bile duct ligation (BDL) or sham-operation. A) Plasma alanine aminotransferase (ALT) activities after Gal/End, BDL or sham-operation (6–72h). Data represent mean ± SE of n=4–6 animals per group. *P<0.05 (compared to untreated control or sham. B) Representative H&E-stained liver sections at 100x or a 400x enhanced Gal/End picture. Apoptotic cells are marked with black arrows; a necrotic cell is indicated by an asterisk.